Gestational insulin-compensated diabetes

Authors

  • Emilio Yaser Pando Hernández Universidad de Ciencias Médicas de Pinar del Río. Facultad de Ciencias Médicas “Dr. Ernesto Che Guevara da la Serna”
  • Carlos Alfredo Miló Valdés Universidad de Ciencias Médicas de Pinar del Río. Facultad de Ciencias Médicas “Dr. Ernesto Che Guevara da la Serna”
  • Raudel Llanio González Universidad de Ciencias Médicas de Pinar del Río. Facultad de Ciencias Médicas “Dr. Ernesto Che Guevara da la Serna”
  • Migdalia de las Mercedes Peña Abrahan Universidad de Ciencias Médicas de Pinar del Río. Hospital General Docente “Abel Santamaría Cuadrado”
  • Eddy Llobany Gonzalez Ungo Universidad de Ciencias Médicas de Pinar del Río. Hospital General Docente “Abel Santamaría Cuadrado”

Keywords:

Diabetes, Gestational, Insulin, Morbidity, Perinatal Care

Abstract

Introduction: the population incidence of gestational diabetes varies approximately between 3 and 10 %, according to ethnic groups, diagnostic criteria and population areas studied and is associated with a higher frequency of maternal and perinatal complications.

Objective: to identify the clinical and epidemiological characteristics of patients with insulin-compensated gestational diabetes.

Method: a prospective, analytical and cross-sectional research was carried out at the “Abel Santamaría Cuadrado” General Teaching Hospital in Pinar del Río during the 2016 - 2018 period. The universe was made up of all the pregnant women treated at the reference institution in the period studied. (N=5967). The sample consisted of a Study Group of 134 pregnant women with insulin-compensated gestational diabetes and the Control Group of 204 diet-compensated diabetics who had their births in the same period.

Results: the group of 20-24 years of age and the diagnoses of gestational diabetes between 19-23 weeks were significant. Predominantly in pregnant women with insulin-compensated gestational diabetes: the normal weights and those with adequate weight gain. The most frequent maternal morbidity was bacterial vaginosis.

Conclusions: insulin-compensated gestational diabetes is not an adverse risk factor for the development of maternal and fetal complications.

Downloads

Download data is not yet available.

Downloads

Published

2019-05-02

How to Cite

1.
Pando Hernández EY, Miló Valdés CA, Llanio González R, Peña Abrahan M de las M, Gonzalez Ungo EL. Gestational insulin-compensated diabetes. Univ. Méd. Pinareña [Internet]. 2019 May 2 [cited 2025 May 6];15(2):194-20. Available from: https://revgaleno.sld.cu/index.php/ump/article/view/340

Issue

Vol. 15 No. 2 (2019): Mayo-Agosto

Section

Original Article

License

Authors who have published with this journal accept the following terms: authors will retain their copyright and guarantee the journal the right of first publication of their work, which will be simultaneously subject to the Creative Commons recognition license that allows third parties to share the work as long as its author is indicated and its first publication is this journal. Authors may adopt other non-exclusive license agreements for the distribution of the version of the published article (e.g., deposit it in an institutional telematic archive or publish it in a monographic volume) provided that the initial publication in this journal is indicated. Authors are permitted and encouraged to disseminate their article using Internet (e.g., in institutional telematic archives or on their website) before and during the submission process, which may lead to interesting exchanges and increased citations of the published work. (See The Effect of Open Access).

Most read articles by the same author(s)